Latest Currency Effects News

ImpediMed reported a $3.5 million revenue in Q3 FY26, with reimbursement coverage in the US reaching 94.3%, supporting growth in heart health and weight management markets. New CEO Erik Anderson aims to accelerate commercial momentum and drive cash flow break-even.

Freelancer Limited’s 1Q26 saw a 14% rise in group GMV to $263.3 million but a 9.4% revenue drop, weighed down by currency headwinds and security-driven user friction. Escrow.com posted record operating profit, while Loadshift grew revenue and media presence amid operational gains.

South32's March quarter saw a tragic fatality at Worsley Alumina and weather disruptions, yet the miner delivered solid operational results and progressed its Hermosa zinc-lead-silver project. Production guidance was mostly maintained, with a notable revision lower for Australia Manganese due to water management issues.

Nanosonics Limited reported a 9% revenue increase in the first half of FY26, driven by a growing installed base and recurring sales, while advancing the commercial rollout of its new CORIS endoscope reprocessing system.

Medical Developments International (MVP) reported an 8% revenue increase driven by strong Penthrox growth, despite a slight EBIT loss impacted by foreign exchange. The company advances pediatric approvals and targets further volume gains.

Nick Scali Limited posted a robust half-year result with revenue up 7.2% and net profit soaring 36.4%, driven by strong ANZ growth despite ongoing UK losses. The company also declared a fully franked interim dividend of 39 cents per share.

Insurance Australia Group’s half year net profit fell 35% to $505 million, weighed down by natural peril claims and integration costs from its RACQI acquisition. Despite this, the insurer maintains its full-year guidance and announces a $200 million share buy-back.

Atlas Arteria reported a 9.5% increase in toll revenue for Q4 2025, driven by steady traffic growth and strategic toll hikes across its global toll road portfolio.

Stakk Limited has surged to an $8.53 million annual recurring revenue run-rate in 2025, propelled by its acquisition of Radical DBX and strong SaaS growth. The fintech’s strategic moves position it for breakeven and further expansion in 2026.

ARB Corporation’s half-year results reveal a modest sales dip driven by Australian OEM challenges, while robust US export growth offers a silver lining.

Harvey Norman Holdings reports a robust 9.1% increase in aggregated sales revenue across key international markets, supported by currency appreciation and selective store openings.

ALS Limited reported a robust half-year performance with underlying revenue up 13.3% and net profit after tax rising 17.2%, driven by strong growth in both Commodities and Life Sciences divisions. The company also declared a higher interim dividend and advanced its global expansion strategy.